"Apropos David's recent Chinese investments and his comments on the premium to NAV on Anthony Bolton's new fund, You/others might be interested to know about a closed-end fund trading at a discount which I have recently stumbled on: The China Fund (NYSE:CHN) managed by Martin Currie. It has a bias to smaller companies. It appears that over half its investments are in the consumer and healthcare sectors."

Eoin Treacy's view Thank you for highlighting this fund which, as you point out, has a comparatively large healthcare weighting. I could not find any details of the fund's charges on their website and am waiting for their marketing department to get back in touch with additional data.

The fund is currently trading at a discount to NAV of 9.36% which is historically quite wide. Prices are retesting the high for the third time since January. A sustained move below $25 would be required to question potential for an upward break.